본문으로 바로가기

의료진 소개

류연주 의사

류연주 교수

호흡기내과, 폐센터, 고위험 산과센터 관심의료진 등록

전문 진료 분야

비결핵항산균폐질환, 기관지확장증, 만성폐쇄성폐질환, 천식, 폐렴, 결핵, 폐암

진료 일정

학력사항

  • 이화여자대학교 의학박사
  • 이화여자대학교 의과대학 졸업

교육 및 연구경력

  • 2017-현재  | 이화여자대학교 의과대학 내과학교실 정교수
  • 2015-2016  | 교환교수 Visiting physician, Mycobacterial and Respiratory infection department in National Jewish Health, Denver, Colorado, USA
  • 2011-2016  | 이화여자대학교 의과대학 내과학교실 부교수
  • 2006-2010  | 이화여자대학교 의과대학 내과학교실 조교수
  • 2005-2006  | 이화여자대학교 동대문병원 호흡기내과 임상강사
  • 2004-2005  | 성균관대학교 삼성서울병원 호흡기내과 연구강사
  • 2003  | 이화여자대학교 목동병원 호흡기내과 연구강사
  • 1999-2002  | 이화여자대학교 의과대학 부속 목동병원 내과 전공의 수료

기타 학술 관련 경력

  • [수상경력]제 1회 결핵예방의날 보건복지부장관상
  • Asian Pacific Society of Respirology 정회원
  • European Respiratory Society 유럽흉부학회 정회원
  • Americam Thoracic Society 미국흉부학회 정회원
  • 대한폐암학회 정회원
  • 2019  | 대한결핵및 호흡기학회 법제위원회
  • 2017-2019  | 대한내과학회 표준진료지침위원회 간사
  • 2014  | 특허( Korean Patent No. 10-1700485, Application No. 10-2014-0182596 Filing date 17th December, 2014/Registration date 20th January, 2017) - Method of subcutaneous fat measurement using by chest CT
  • 2012-2013  | Inclusion in the new Who’s Who in the World 2012 (29th Edition) 마르퀴즈 후즈후 등재
  • 2011  | The Minister of Health and Welfare’s citation for World TB (tuberculosis) day

논문

  •  Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer.  Journal of Clinical Medicine. 2022, v.11 no.9, 2391. 
  •  Clinical characteristics and outcomes among older nursing home residents hospitalized with pneumonia.  Archives of Gerontology and Geriatrics. 2021, v.95, 104394. 
  •  Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types.  BMC Cancer. 2021 , 52. 
  •  대한내과학회가 드리는“안전한 약물 복용 지침”.  대한내과학회지. 2021, v.96 no.3, 225-235. 
  •  Clinical features and outcomes in patients with pulmonary complications during pregnancy and peripartum.  JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE. 2020, v.33 no.7, 1191-1196. 
  •  Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study.  PLOS ONE. 2020, v.15 no.2, e0228925. 
  •  Diagnostic yield of additional conventional transbronchial lung biopsy following radial endobronchial ultrasound lung biopsy for peripheral pulmonary lesions.  Thoracic Cancer. 2020, v.11 no.6, 1639-1646. 
  •  Impact of right ventricular systolic pressure in elderly patients admitted to intensive care unit after femur fracture surgery: A retrospective observational study.  Medicine. 2020, v.99 no.45, e22881. 
  •  Adenovirus pneumonia treated with Cidofovir in an immunocompetent high school senior.  Respiratory Medicine Case Reports. 2019, v.26, 215-218. 
  •  Clinical characteristics of patients with newly developed acute cholecystitis after admission to the intensive care unit.  AUSTRALIAN CRITICAL CARE. 2019, v.32 no.3, 223-228. 
  •  Hemoptysis requiring bronchial artery embolization in patients with nontuberculous mycobacterial lung disease.  BMC PULMONARY MEDICINE. 2019, v.19, 117. 
  • Yoon HY, Shim SS, Kim SJ, Lee JH, Chang JH, Lee SH, Ryu YJ. Long-Term Mortality and Prognostic Factors in Aspiration Pneumonia.  J Am Med Dir Assoc. 2019 May 9. pii: S1525-8610(19). 
  •  Combined silicosis and mixed dust pneumoconiosis with rapid progression: A case report and literature review..  World J Clin Cases. 2018-12. 
  •  Clinical outcomes and prognostic factors in patients directly transferred to the intensive care unit from long-term care beds in institutions and hospitals: a retrospective clinical study. .  BMC Geriatrics. 2018-10. 
  •  Clinical features and outcomes in patients with pulmonary complications during pregnancy and peripartum.  J Matern Fetal Neonatal Med. 2018-09. 
  •  Clinical characteristics of patients with newly developed acute cholecystitis after admission to the intensive care unit. .  Australian crit care . 2018-08. 
  •  The effect of diabetes control status on treatment response in pulmonary tuberculosis: a prospective study. .  Thorax. 2017-02. 
  •  Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives.  Tuberc Respir Dis. 2016-04. 
  •  Choice between Levofloxacin and Moxifloxacin and Multidrug-Resistant Tuberculosis Treatment Outcomes.  Ann Am Thorac Soc. 2016-03. 
  •  Clinical Features and Outcomes of Respiratory Complications in Patients with Thoracic Hyperkyphosis. .  LUNG. 2015-12. 
  •  Prognosis and Predictors of Rebleeding After Bronchial Artery Embolization in Patients with Active or Inactive Pulmonary Tuberculosis. .  LUNG. 2015-10. 
  •  Factors that Predict Negative Results of QuantiFERON-TB Gold In-Tube Test in Patients with Culture-Confirmed Tuberculosis: A Multicenter Retrospective Cohort Study.  PLoS One. 2015-06. 
  •  Diagnosis of pulmonary tuberculosis: recent advances and diagnostic algorithms. .  Tuberc Respir Dis. 2015-04. 
  •  The impact of low subcutaneous fat in patients with nontuberculous mycobacterial lung disease.  LUNG. 2014-10. 
  •  Clinical features and prognostic factors in elderly koreans with advanced non-small-cell lung cancer in a tertiary referral hospital..  Tuberc Respir Dis. 2013-10. 
  •  Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung. .  Int J Tuberc Lung Dis.. 2011-02. 
  •  Prevalence of depression and anxiety in outpatients with chronic airway lung disease.  Korean J Intern Med. 2010-03. 
  •  Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias.  Respir Med. 2007-10. 
  •  Prognostic factors in pulmonary tuberculosis requiring mechanical ventilation for acute respiratory failure. .  Respirology. 2007-05. 
  •  Impaired expression of toll-like receptor 2 in nontuberculous mycobacterial lung disease.  European respiratory journal. 2007-04. 
  •  Toll-like receptor 2 polymorphisms and nontuberculous mycobacterial lung diseases.  Clin Vaccine Immunol. 2006-07. 
  •  Use of silicone stents for the management of post-tuberculosis tracheobronchial stenosis.  European respiratory journal. 2006-04. 
  •  Comparison of Natural and Dumon airway stents for the management of benign tracheobronchial stenoses. .  Respirology. 2006-03.